Chinese-American, microbiologist, postdoctoral fellow, and national-level foreign expert. One of the founders of the company. He has long been committed to the study of tumorigenesis mechanisms and original research on recombinant fusion protein innovative drugs, and has profound knowledge in the original research and industrialization of biological innovative drugs in China.